Fig. 9From: Systemically administered allogeneic mesenchymal stem cells do not aggravate the progression of precancerous lesions: a new biosafety insightSystemically administered allogeneic MSCs rarely home into precancerous lesions. At hyperplasia, dysplasia, or papilloma stage, hamsters received intracardially 21 × 106 CMTPX-labeled MSCs/kg. One day later, donor cells were sought in precancerous lesions. Bar = 50 μm (number of replicates = 6, n = 3)Back to article page